| |
| |
| |
| Introduction to Clinical Exercise Physiology | |
| |
| |
| |
| Introduction | |
| |
| |
| |
| The Past, Present and Future of Clinical Exercise Physiology | |
| |
| |
| Professional Organizations and Certifications | |
| |
| |
| Professionalization of Clinical Exercise Physiology | |
| |
| |
| Conclusion | |
| |
| |
| |
| Behavioral Approaches to Physical Activity Promotion | |
| |
| |
| |
| Benefits of Physical Activity | |
| |
| |
| Issues Related to Regular Physical Activity Participation | |
| |
| |
| Conclusion | |
| |
| |
| |
| Pharmacotherapy | |
| |
| |
| |
| Metabolic Diseases and Agents Cardiovascular Diseases and Agents | |
| |
| |
| Pulmonary Diseases and Agents | |
| |
| |
| Immunologic Diseases and Agents Orthopedic and Musculoskeletal Diseases and Agents Neuromuscular Diseases and Agents | |
| |
| |
| Psychiatric Diseases and Agents | |
| |
| |
| Conclusion | |
| |
| |
| |
| General Evaluation and Examination Skills | |
| |
| |
| |
| General Interview | |
| |
| |
| Physical Examination | |
| |
| |
| Conclusion | |
| |
| |
| |
| Graded Exercise Testing and Exercise Prescription | |
| |
| |
| |
| Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Special Populations | |
| |
| |
| |
| Children | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Assessment of Physical Activity in Children | |
| |
| |
| Recommendations and Anticipated Responses | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| The Elderly | |
| |
| |
| |
| Scope | |
| |
| |
| Physiology and Pathology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Female-Specific Issues | |
| |
| |
| |
| Female-Specific Issues | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Depression and Exercise | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Endocrinology and Metabolic Disorders | |
| |
| |
| |
| Metabolic Syndrome | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| |
| Diabetes | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Obesity | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Hypertension | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Hyperlipidemia and Dyslipidemia | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| |
| End-Stage Renal Disease | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Cardiovascular Diseases | |
| |
| |
| |
| Myocardial Infarction | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Revascularization of the Heart | |
| |
| |
| |
| Coronary Artery Bypass Surgery | |
| |
| |
| Percutaneous Interventions | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Chronic Heart Failure | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Peripheral Arterial Disease | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Pacemakers and Internal Cardiac Defibrillators | |
| |
| |
| |
| Scope and Pathophysiology | |
| |
| |
| Pacing System | |
| |
| |
| Exercise Physiology | |
| |
| |
| Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Diseases of the Respiratory System | |
| |
| |
| |
| Chronic Obstructive Pulmonary Disease | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Asthma | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Cystic Fibrosis | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Oncology and the Immune System | |
| |
| |
| |
| Cancer | |
| |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Human Immunodeficiency Virus | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Disorders of the Bone and the Joints | |
| |
| |
| |
| Arthritis | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Osteoporosis | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Nonspecific Low Back Pain | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| History | |
| |
| |
| Physical Examination | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Selected Neuromuscular Disorders | |
| |
| |
| |
| Spinal Cord Injury | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Conclusion | |
| |
| |
| |
| Multiple Sclerosis | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Cerebral Palsy | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Testing | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |
| |
| |
| |
| Stroke | |
| |
| |
| |
| Scope | |
| |
| |
| Pathophysiology | |
| |
| |
| Medical and Clinical Considerations | |
| |
| |
| Exercise Prescription | |
| |
| |
| Exercise Training | |
| |
| |
| Conclusion | |